{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:16:49Z","timestamp":1788171409649,"version":"build-2803163510"},"reference-count":28,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>National registries are essential infrastructure for haemophilia and allied bleeding disorders, but registry development and international alignment across the Asia\u2013Pacific region remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the availability, governance, technical infrastructure, international engagement, and patient\u2010facing digital functions of national haemophilia registries across the Asia\u2013Pacific region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The AHAD\u2010AP Registry Committee conducted a structured survey of Country\/Region\/Territory (CRT) representatives. The questionnaire assessed registry status, funding and governance, international alignment, technical infrastructure, data\u2010entry methods, and digital functions. Multiple responses from the same CRT were harmonized when needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nineteen individual responses representing 15 CRTs were consolidated into 15 CRT\u2010level responses. Ten CRTs reported an active national registry, one a planned registry, three no national registry, of which two had centres participating in World Bleeding Disorders Registry (WBDR), and one hospital\u2010based registry. Haemophilia was included in all, while VWD and other inherited coagulation factor deficiencies were included in 11 of 12. Mandatory registration was reported by 5 CRTs. Funding and governance structures varied across CRTs. Awareness of WBDR was reported by 12 of 15 CRTs, while dataset alignment, data submission, and technical integration were reported by 8, 4, and 1 CRTs, respectively. Manual data entry remained common (9\/12), and patient\u2010oriented digital functions, including infusion logs or related support tools, were reported by 10 of 12 registries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This survey represents the first large regional assessments of national haemophilia registry infrastructure across the Asia\u2013Pacific region. Harmonized datasets, sustainable governance, technical integration, and patient\u2010facing digital tools may support future registry development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hae.70395","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:34:56Z","timestamp":1788168896000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Status of National Haemophilia Registries in the Asia\u2013Pacific Region: An AHAD\u2010AP Registry Committee Survey"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-1498","authenticated-orcid":false,"given":"Azusa","family":"Nagao","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology Kansai Medical University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-959X","authenticated-orcid":false,"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[{"name":"Haemophilia Treatment Centre, Thrombosis &amp; Haemostasis Unit The Alfred Hospital  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-7332","authenticated-orcid":false,"given":"M. Joseph","family":"John","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Haemato\u2010Oncology &amp; Bone Marrow (Stem Cell) Transplantation Christian Medical College  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-0863","authenticated-orcid":false,"given":"Jameela","family":"Sathar","sequence":"additional","affiliation":[{"name":"Ministry of Health Ampang Hospital  Kuala Lumpur Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-4179","authenticated-orcid":false,"given":"Novie","family":"Chozie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Cipto Mangunkusumo Hospital Universitas Indonesia  Jakarta Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8936-1205","authenticated-orcid":false,"given":"Jung Woo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Yonsei University College of Medicine  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-6899","authenticated-orcid":false,"given":"Veena","family":"Selvaratnam","sequence":"additional","affiliation":[{"name":"Hospital Ampang  Ampang Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7485-6018","authenticated-orcid":false,"given":"Mai Thi","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Hemophilia Center National Institute of Hematology and Blood Transfusion  Hanoi Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6954-0492","authenticated-orcid":false,"given":"Chean","family":"Soph\u00e2l","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Immunology and Transfusion Medicine, Hemophilia Treatment Center National Pediatric Hospital  Phnom Penh Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0948-465X","authenticated-orcid":false,"given":"Kumiko","family":"Ono","sequence":"additional","affiliation":[{"name":"Center For Hemophilic Arthropathy The University of Tokyo Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-8671","authenticated-orcid":false,"given":"Te\u2010Fu","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Chung Shan Medical University Hospital  Taichung City Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-3482","authenticated-orcid":false,"given":"Darintr","family":"Sosothikul","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Faculty of Medicine, Division of Pediatric Hematology and Oncology Chulalongkorn University  Bangkok Thailand"},{"name":"Center of Excellence in Pediatric Hematology\/Oncology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital  Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-5020","authenticated-orcid":false,"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Haematology Research Unit, St. John's Research Institute and St. John's Medical College Hospital  Bengaluru India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"3","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/hae.14993","article-title":"The Importance and Evolution of Bleeding Disorder Registries","volume":"30","author":"Tran H.","year":"2024","journal-title":"Haemophilia"},{"issue":"5","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/hae.13072","article-title":"Standardizing Patient Outcomes Measurement to Improve Haemophilia Care","volume":"22","author":"Srivastava A.","year":"2016","journal-title":"Haemophilia"},{"key":"e_1_2_10_4_1","unstructured":"Annual Global Survey.World Federation of Hemophilia."},{"issue":"3","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/hae.13425","article-title":"Principles of Haemophilia Care: The Asia\u2010Pacific Perspective","volume":"24","author":"Dunkley S.","year":"2018","journal-title":"Haemophilia"},{"key":"e_1_2_10_6_1","unstructured":"AHAD\u2010AP homepage.AHADAP(2022)."},{"issue":"4","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/j.amepre.2011.09.018","article-title":"A Community\u2010Based Partnership to Promote Information Infrastructure for Bleeding Disorders","volume":"41","author":"Aschman D. J.","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"issue":"3","key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1111\/hae.13431","article-title":"World Bleeding Disorders Registry: The Pilot Study","volume":"24","author":"Coffin D.","year":"2018","journal-title":"Haemophilia"},{"key":"e_1_2_10_9_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101164","article-title":"Nothing Short of a Revolution: Novel Extended Half\u2010life Factor VIII Replacement Products and Non\u2010replacement Agents Reshape the Treatment Landscape in Hemophilia A","volume":"64","author":"Abdelgawad H. A. H.","year":"2024","journal-title":"Blood Reviews"},{"issue":"3","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12695","article-title":"Impact of novel hemophilia therapies around the world","volume":"6","author":"Ozelo M. C.","year":"2022","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"3","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/hae.14976","article-title":"Benefits and risks of non\u2010factor therapies: Redefining haemophilia treatment goals in the era of new technologies","volume":"30","author":"Mancuso M. E.","year":"2024","journal-title":"Haemophilia: The Official Journal of the World Federation of Hemophilia"},{"issue":"3","key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jtha.2025.12.011","article-title":"Overview of Gene Therapy for Hemophilia: Questions and Answers to Navigate the Innovation","volume":"24","author":"Hoffmann P.","year":"2026","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"issue":"4","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/hae.13443","article-title":"Prospects for Research in Haemophilia With Real\u2010World Data\u2014An Analysis of German Registry and Secondary Data","volume":"24","author":"Schopohl D.","year":"2018","journal-title":"Haemophilia"},{"key":"e_1_2_10_14_1","unstructured":"European Medicines Agency.Real\u2010world evidence. Accessed June 9 2026.https:\/\/www.ema.europa.eu\/en\/about\u2010us\/how\u2010we\u2010work\/data\u2010regulation\u2010big\u2010data\u2010other\u2010sources\/real\u2010world\u2010evidence."},{"key":"e_1_2_10_15_1","unstructured":"M.Semienchuk World Federation of Hemophilia &National Bleeding Disorders Foundation \u201cWFH and NBDF Statement on Severe Adverse Event With Marstacimab Rebalancing Agent for Hemophilia \u201d (World Federation of Hemophilia 2025)."},{"issue":"1","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/hae.70196","article-title":"The First Three Japanese Haemophilia A Patients in Whom Factor VIII Inhibitors Were Observed During Prophylactic Treatment With Efanesoctocog Alfa","volume":"32","author":"Tokugawa T.","year":"2026","journal-title":"Haemophilia: The Official Journal of the World Federation of Hemophilia"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0049-3848(10)70150-X","article-title":"EUHASS: The European Haemophilia Safety Surveillance System","volume":"127","author":"Makris M.","year":"2011","journal-title":"Thrombosis Research"},{"issue":"3","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/hae.70250","article-title":"Challenges and Opportunities in Post\u2010Marketing Reporting of Factor VIII Inhibitors with Efanesoctocog Alfa","volume":"32","author":"Dumont J.","year":"2026","journal-title":"Haemophilia"},{"issue":"9","key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/jth.13762","article-title":"Minimal Dataset for Post\u2010Registration Surveillance of New Drugs in Hemophilia: Communication From the SSC of the ISTH","volume":"15","author":"Peyvandi F.","year":"2017","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2516.2005.01114.x","article-title":"Recommendations for Postmarketing Surveillance Studies in Haemophilia and Other Bleeding Disorders","volume":"11","author":"Lassila R.","year":"2005","journal-title":"Haemophilia"},{"issue":"1","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13023-024-03193-y","article-title":"Scoping Review of the Recommendations and Guidance for Improving the Quality of Rare Disease Registries","volume":"19","author":"Tarride J.","year":"2024","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"e_1_2_10_22_1","unstructured":"National Blood Authority.Australian Bleeding Disorders Registry.Australian Government."},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCREGISTRIES4","volume-title":"Registries for Evaluating Patient Outcomes: A User's Guide","author":"Gliklich R. E.","year":"2020"},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.924648","article-title":"Contribution of Patient Registries to Regulatory Decision Making on Rare Diseases Medicinal Products in Europe","volume":"13","author":"Jonker C. J.","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"e_1_2_10_25_1","volume-title":"Registries for Evaluating Patient Outcomes: A User's Guide","author":"Gliklich R. E.","year":"2014"},{"issue":"1","key":"e_1_2_10_26_1","first-page":"1","article-title":"Automating Data Entry From Electronic Health Record to Electronic Data Capture Using Trusted Cloud\u2010Based Application in Multisite Cancer Clinical Trials","volume":"5","author":"Goodman K.","year":"2025","journal-title":"Journal of the Society for Clinical Data Management"},{"issue":"12","key":"e_1_2_10_27_1","doi-asserted-by":"crossref","DOI":"10.2196\/25071","article-title":"An Electronic Patient\u2010Reported Outcome Mobile App for Data Collection in Type A Hemophilia: Design and Usability Study","volume":"5","author":"Petracca F.","year":"2021","journal-title":"JMIR Formative Research"},{"issue":"6","key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/hae.14178","article-title":"Quality of Electronic Treatment Records and Adherence to Prophylaxis in Haemophilia and von Willebrand Disease: Systematic Assessments From an Electronic Diary","volume":"26","author":"Tiede A.","year":"2020","journal-title":"Haemophilia: The Official Journal of the World Federation of Hemophilia"},{"issue":"4","key":"e_1_2_10_29_1","first-page":"e120","article-title":"Direct Transfer of Data of People With Haemophilia From the Thai Haemophilia Treatment Centre Registry to the World Bleeding Disorders Registry of the World Federation of Hemophilia","volume":"28","author":"Chuansumrit A.","year":"2022","journal-title":"Haemophilia"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.70395","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.70395","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.70395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:35:01Z","timestamp":1788168901000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.70395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":28,"alternative-id":["10.1111\/hae.70395"],"URL":"https:\/\/doi.org\/10.1111\/hae.70395","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"2026-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"hae.70395"}}